Cardiva Medical has developed an innovative approach to safe, arteriotomy site-specific compression, hemostasis, boomerang effect, secure vascular closure without leaving anything behind in the artery or tissue tract.
 
 About Us   :   
 Products   :   
 Healthcare Professionals   :   
 Patients   :   
 Newsroom   :   
 Contact Us   
 
Spotlight: FDA APPROVES VASCADE™ VCS
Cardiva Catalyst™ Family
VASCADE™ VCS
The VASCADE™ Vascular closure System (VCS) is a new generation extravascular closure device designed to increase the comfort and safety of vascular closure for patients.
Cardiva Catalyst™ Family
Cardiva Catalyst™ Family
The Cardiva Catalyst™ is designed to increase the comfort of the manual compression process and facilitate the body’s healing process.
Ordering
Ordering
For order information, please contact Cardiva Customer Service
1-866-602-6099
News & Events
August 19, 2014
Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital
January 20, 2014
Cardiva Medical, Inc. Announces Appointment of Randy Hubbell, Chief Commercial Officer
February 6, 2013
Cardiva Medical, Inc. Announces FDA approval of VASCADE™ Vascular Closure System
September 25, 2012
Cardiva Medical, Inc. announces that it has obtained approval to apply the European CE Mark to its VASCADE™ Vascular Closure System (VCS)
August 9, 2012
Cardiva Medical, Inc. Completes Third Tranche of Series 2 Private Equity Financing
August 2, 2012
Cardiva Medical, Inc. submits final PMA module to FDA for VASCADE™ Vascular Closure System
June 20, 2012
Cardiva Medical, Inc. Announces Completion of Enrollment in the RESPECT Clinical Trial Aimed at Demonstrating the Safety and Efficacy of the VASCADE™ Vascular Closure System

 

 2013  Cardiva Medical, Inc.  
   :    Privacy Policy